FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204176899> ?p ?o ?g. }

• W3204176899 abstract "Severe fever with thrombocytopenia syndrome (SFTS) virus (SFTSV) is an emerging tick-borne virus with high fatality and an expanding endemic. Currently, effective anti-SFTSV intervention remains unavailable. Favipiravir (T-705) was recently reported to show in vitro and in animal model antiviral efficacy against SFTSV. Here, we conducted a single-blind, randomized controlled trial to assess the efficacy and safety of T-705 in treating SFTS (Chinese Clinical Trial Registry website, number ChiCTR1900023350). From May to August 2018, laboratory-confirmed SFTS patients were recruited from a designated hospital and randomly assigned to receive oral T-705 in combination with supportive care or supportive care only. Fatal outcome occurred in 9.5% (7/74) of T-705 treated patients and 18.3% (13/71) of controls (odds ratio, 0.466, 95% CI, 0.174-1.247). Cox regression showed a significant reduction in case fatality rate (CFR) with an adjusted hazard ratio of 0.366 (95% CI, 0.142-0.944). Among the low-viral load subgroup (RT-PCR cycle threshold ≥26), T-705 treatment significantly reduced CFR from 11.5 to 1.6% (P = 0.029), while no between-arm difference was observed in the high-viral load subgroup (RT-PCR cycle threshold <26). The T-705-treated group showed shorter viral clearance, lower incidence of hemorrhagic signs, and faster recovery of laboratory abnormities compared with the controls. The in vitro and animal experiments demonstrated that the antiviral efficacies of T-705 were proportionally induced by SFTSV mutation rates, particularly from two transition mutation types. The mutation analyses on T-705-treated serum samples disclosed a partially consistent mutagenesis pattern as those of the in vitro or animal experiments in reducing the SFTSV viral loads, further supporting the anti-SFTSV effect of T-705, especially for the low-viral loads." @default.
• W3204176899 created "2021-10-11" @default.
• W3204176899 creator A5003547177 @default.
• W3204176899 creator A5009091338 @default.
• W3204176899 creator A5009246691 @default.
• W3204176899 creator A5010010686 @default.
• W3204176899 creator A5011103330 @default.
• W3204176899 creator A5016306625 @default.
• W3204176899 creator A5018892762 @default.
• W3204176899 creator A5019421112 @default.
• W3204176899 creator A5019560977 @default.
• W3204176899 creator A5029228548 @default.
• W3204176899 creator A5031057559 @default.
• W3204176899 creator A5035363378 @default.
• W3204176899 creator A5038195995 @default.
• W3204176899 creator A5047395175 @default.
• W3204176899 creator A5047906405 @default.
• W3204176899 creator A5048196920 @default.
• W3204176899 creator A5049433267 @default.
• W3204176899 creator A5049692788 @default.
• W3204176899 creator A5053202587 @default.
• W3204176899 creator A5058506093 @default.
• W3204176899 creator A5060830739 @default.
• W3204176899 creator A5065058975 @default.
• W3204176899 creator A5065545649 @default.
• W3204176899 creator A5065552836 @default.
• W3204176899 creator A5070995411 @default.
• W3204176899 creator A5071037763 @default.
• W3204176899 creator A5072548035 @default.
• W3204176899 creator A5078581090 @default.
• W3204176899 creator A5081728299 @default.
• W3204176899 creator A5083836736 @default.
• W3204176899 creator A5087380736 @default.
• W3204176899 creator A5088104037 @default.
• W3204176899 date "2021-04-16" @default.
• W3204176899 modified "2023-10-17" @default.
• W3204176899 title "Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome" @default.
• W3204176899 cites W1803488479 @default.
• W3204176899 cites W1995119224 @default.
• W3204176899 cites W2019731276 @default.
• W3204176899 cites W2022434050 @default.
• W3204176899 cites W2030160453 @default.
• W3204176899 cites W2031438581 @default.
• W3204176899 cites W2033300352 @default.
• W3204176899 cites W2039941020 @default.
• W3204176899 cites W2041097615 @default.
• W3204176899 cites W2048863472 @default.
• W3204176899 cites W2088152248 @default.
• W3204176899 cites W2102978013 @default.
• W3204176899 cites W2103612325 @default.
• W3204176899 cites W2108234281 @default.
• W3204176899 cites W2126245676 @default.
• W3204176899 cites W2128349139 @default.
• W3204176899 cites W2130394030 @default.
• W3204176899 cites W2138274210 @default.
• W3204176899 cites W2138992015 @default.
• W3204176899 cites W2140965090 @default.
• W3204176899 cites W2144520445 @default.
• W3204176899 cites W2166280456 @default.
• W3204176899 cites W2172081451 @default.
• W3204176899 cites W2296414617 @default.
• W3204176899 cites W2308572722 @default.
• W3204176899 cites W2343010189 @default.
• W3204176899 cites W2418219898 @default.
• W3204176899 cites W2512126238 @default.
• W3204176899 cites W2517370544 @default.
• W3204176899 cites W2560087488 @default.
• W3204176899 cites W2589138774 @default.
• W3204176899 cites W2595639244 @default.
• W3204176899 cites W2636610941 @default.
• W3204176899 cites W2759463260 @default.
• W3204176899 cites W2790212385 @default.
• W3204176899 cites W2791347300 @default.
• W3204176899 cites W2794468699 @default.
• W3204176899 cites W2884802662 @default.
• W3204176899 cites W2902860717 @default.
• W3204176899 cites W2909169526 @default.
• W3204176899 cites W2927565072 @default.
• W3204176899 cites W2952446482 @default.
• W3204176899 cites W2969650679 @default.
• W3204176899 cites W2969900355 @default.
• W3204176899 cites W2975881654 @default.
• W3204176899 cites W2982330046 @default.
• W3204176899 cites W3017290399 @default.
• W3204176899 cites W3032995094 @default.
• W3204176899 cites W898301972 @default.
• W3204176899 doi "https://doi.org/10.1038/s41392-021-00541-3" @default.
• W3204176899 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8050330" @default.
• W3204176899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33859168" @default.
• W3204176899 hasPublicationYear "2021" @default.
• W3204176899 type Work @default.
• W3204176899 sameAs 3204176899 @default.
• W3204176899 citedByCount "29" @default.
• W3204176899 countsByYear W32041768992021 @default.
• W3204176899 countsByYear W32041768992022 @default.
• W3204176899 countsByYear W32041768992023 @default.
• W3204176899 crossrefType "journal-article" @default.
• W3204176899 hasAuthorship W3204176899A5003547177 @default.
• W3204176899 hasAuthorship W3204176899A5009091338 @default.
• W3204176899 hasAuthorship W3204176899A5009246691 @default.

• next